Indonesia Clinical Laboratory Market is Expected to Reach USD 3.2 Billion by
2022: Ken Research
Indonesia clinical laboratory market segment (by type of clinical laboratory, by type of private
independent laboratory, by type of customer, by payer, by type of test and by region), competitive
landscape of major players in Indonesia clinical laboratory market, and covering company profile of
major clinical labs including Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika and
Parahita. The report concludes with market projection for future and analyst recommendations
highlighting the major opportunities and cautions.
February 2018 | Indonesia News
The healthcare market in Indonesia was majorly impacted by the implementation of JKN
(Indonesian National Health Insurance) as the demand for affordable/primary
healthcare services, laboratory services, and generic medicines increased.
The private independent clinical laboratory market is dominated by organized
laboratory chains. Prodia is the market leader in Indonesia Clinical Laboratory Market
supported by the largest labs network and experienced management team.
Indonesia Healthcare market will be facilitated by the rising number of healthcare providers
coupled with elevating prevalence of chronic diseases such as diabetes, HIV, Tuberculosis
and others. More than 35,000 new beds are likely to be added in Indonesia by 2020.